TY  - CHAP
M1  - Book, Section
TI  - Hypertension
A1  - Saseen, Joseph J.
A1  - MacLaughlin, Eric J.
A2  - DiPiro, Joseph T.
A2  - Talbert, Robert L.
A2  - Yee, Gary C.
A2  - Matzke, Gary R.
A2  - Wells, Barbara G.
A2  - Posey, L. Michael
PY  - 2017
T2  - Pharmacotherapy: A Pathophysiologic Approach, 10e
AB  - Patient  Care  Process  for  the  Management  of  HypertensionCollectPatient  characteristics  (e.g.,  age,  race,  sex,  pregnant)Patient  history  (past  medical,  family,  social  —  dietary  habits,  tobacco  use)Home  blood  pressure  (BP)  readingsCurrent  medications  and  prior  anti-hypertensive  medication  useObjective  data  (see  Box  13-1)BP,  heart  rate  (HR),  height,  weight,  and  BMILabs  (e.g.  serum  electrolytes,  Scr,  BUN)Other  diagnostic  tests  when  indicated  (e.g.  ECG)AssessPresence  of  compelling  indications  (e.g.  coronary  artery  disease,  chronic  kidney  disease;  see  Figure  13-3)Hypertension-related  complications  (e.g.  albuminuria,  retinopathy;  see  Box  13-1)10-year  Atherosclerotic  cardiovascular  disease  (ASCVD)  risk  when  indicatedCurrent  medications  that  may  contribute  to  or  worsen  hypertensionBP  goal  and  whether  goal  has  been  achieved  (see  Box  13-2)Appropriateness  and  effectiveness  of  current  antihypertensive  regimenFor  resistant  hypertension  if  taking  3  or  more  antihypertensive  medications  (see  Table  13-10)Plan*Tailored  lifestyle  modifications  (e.g.  diet,  exercise,  weight  management;  see  Table  13-4)Drug  therapy  regimen  including  specific  antihypertensive(s),  dose,  route,  frequency,  and  duration;  specify  the  continuation  and  discontinuation  of  existing  therapies  (see  Tables  13-5,  13-6,  13-7,  and  13-9)Monitoring  parameters  including  efficacy  (e.g.  BP,  cardiovascular  events,  kidney  health),  safety  (medication-specific  adverse  effects),  and  timeframe  (see  Table  13-8)Patient  education  (e.g.  purpose  of  treatment,  dietary  and  lifestyle  modification,  drug  therapy)Self-monitoring  of  BP,  HR,  and  weight  —  where  and  how  to  record  resultsReferrals  to  other  providers  when  appropriate  (e.g.  physician,  dietician)Implement*Provide  patient  education  regarding  all  elements  of  treatment  planUse  motivational  interviewing  and  coaching  strategies  to  maximize  adherenceSchedule  follow-upFollow-up:  Monitor  and  EvaluateDetermine  BP  goal  attainmentPresence  of  adverse  effectsOccurrence  of  CV  events  and  development/progression  of  kidney  impairmentPatient  adherence  to  treatment  plan  using  multiple  sources  of  information*Collaborate  with  patient,  caregivers,  and  other  health  professionals  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1167762493
ER  -